Our analysis revealed outcome-associated tumor-intrinsic gene signatures, cancer hallmarks, and early-stage drivers that together indicated that the HSP90-MYC-CDK9 network drives tumor evolution and sequential resistance. The gene discussed is CDK9; the disease is cancer.